Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 28, 2025

The Year in Crypto ETFs 2025: Bitcoin, Ethereum Thrive as XRP and More Join the Party

View original at finance.yahoo.com
The Year in Crypto ETFs 2025: Bitcoin, Ethereum Thrive as XRP and More Join the Party This year, exchange-traded funds opened several doors to crypto on Wall Street, as the SEC forged a fresh approach to the products…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • At least a dozen cryptocurrencies were instantly 'good to go' after the SEC approved generic listing standards

    80% confidence
  • The shift from retail to institutional investors is very good for long-term sustainability of the crypto asset class because institutions have much longer-term time horizons

    80% confidence
  • Questions aren't really whether professional investors should get crypto exposure, but how they should get exposure

    80% confidence
  • The shift to institutional investors hasn't been dramatic but has been notable

    80% confidence
  • Many advisors and professional investors are still in due diligence for crypto ETFs but could start thinking seriously about allocations soon

    80% confidence
  • Asset managers are still waiting for answers on at least 126 ETFs

    80% confidence
  • XRP and Solana communities are much more engaged, stronger and larger than many people thought, which bodes well for both ecosystems going into 2026

    80% confidence
  • XRP and Solana ETFs haven't had the expected effect on price but have been huge successes and validation of investor appetite beyond Bitcoin and Ethereum

    80% confidence
  • The debut of ETFs for Solana and XRP came at a disadvantageous time in November with macroeconomic conditions driving digital-asset prices lower

    80% confidence
  • Professional investors can make an allocation to an index ETF and get broad exposure to crypto growth potential without detailed knowledge of individual assets

    80% confidence
  • The approval of generic listing standards was expected

    80% confidence
  • ETFs that track an index of digital assets will become a bigger part of the conversation next year

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com